Improvement in Patient-Reported Outcomes in a Rituximab Trial in Patients With Severe Rheumatoid Arthritis Refractory to Anti-Tumor Necrosis Factor Therapy.
Saved in:
| Title: | Improvement in Patient-Reported Outcomes in a Rituximab Trial in Patients With Severe Rheumatoid Arthritis Refractory to Anti-Tumor Necrosis Factor Therapy. |
|---|---|
| Authors: | Keystone, E.1 edkeysteone@mtsinai.on.ca, Burmester, G. R.2, Fume, R.3, Loveless, J. E.4, Emery, P.5, Kremer, J.6, Tak, P. P.7, Broder, M. S.8, Yu, E.9, Cravets, M.10, Magrini, F.11, Jost, F.12 |
| Source: | Arthritis & Rheumatism. Jun2008, Vol. 58 Issue 6, p785-793. 9p. 5 Charts, 3 Graphs. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
